Eledon Pharmaceuticals dismisses Crowe LLP, appoints Deloitte as auditor

Eledon Pharmaceuticals, Inc.

Audit Committee dismissed Crowe LLP as independent auditor effective April 1, 2025.
No disagreements or reportable events in fiscal years 2023 and 2024 or interim period.
Crowe's audit reports for 2023 and 2024 were unqualified and not modified.
Deloitte & Touche LLP appointed as new auditor for fiscal year ending Dec 31, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.